Looking at the global market, GLP-1RA has steadily increased its share in the market of hypoglycemic drugs
doi:10.1046/j.1523-1747.1999.00684.x Scott Froum, DDS, a graduate of the State University of New York, Stony Brook School of Dental Medicine, is a periodontist in private practice at 1110 2nd Avenue, Suite 305, New York City, New York
Pancreatitis Drug action on GLP-1 receptors of the pancreas and exocrine ducts may cause cellular overgrowth, hyperplasia, and duct occlusion
By the 1990s it had become apparent that GLP-1 not only played an important role in the stimulation of insulin but could also have broader physiological actions beyond the pancreas
doi: 10.3389/fendo.2021.678055 18 de GraafCDonnellyDWoottenDLauJSextonPMMillerLJet al
Protective role of autophagy in AGE-induced early injury of human vascular endothelial cells